Anatomical Retinal Changes after Photodynamic Therapy in Chronic Central Serous Chorioretinopathy

被引:10
作者
Pilar Ruiz-del-Tiempo, Maria [1 ]
Calvo, Pilar [2 ,3 ]
Ferreras, Antonio [2 ,3 ]
Lecinena, Jesus [2 ]
Pablo, Luis [2 ,3 ]
Ruiz-Moreno, Oscar [2 ,3 ]
机构
[1] Gregorio Maranon Univ, Gen Hosp, Dept Ophthalmol, Madrid, Spain
[2] Miguel Servet Univ Hosp, IIS Aragon, Dept Ophthalmol, Zaragoza, Spain
[3] Univ Zaragoza, Zaragoza, Spain
关键词
FOVEAL PHOTORECEPTOR LAYER; HALF-DOSE VERTEPORFIN; VISUAL-ACUITY; FOLLOW-UP;
D O I
10.1155/2018/4081874
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. To evaluate anatomical retinal changes measured by spectral-domain optical coherence tomography (SD-OCT), after applying photodynamic therapy (PDT) for treatment of chronic central serous chorioretinopathy (CSC). Methods. A retrospective analysis was conducted on 43 patients (48 eyes) with chronic CSC treated with PDT. Visual acuity (VA), central retinal thickness (CRT), outer nuclear layer (ONL) thickness, subretinal fluid (SRF), and photoreceptor ellipsoid zone (EZ) measured by SD-OCT were collected at baseline and at 3, 6, and 12 months after PDT. Differences between normally distributed variables were calculated by a paired-sample t-test; p < 0 05 was considered statistically significant. Results. Mean age was 50 +/- 9.8 years. Mean time from diagnosis to PDT was 12.5 months. Baseline VA was 0.51 +/- 0.24 and significantly improved (p < 0 001) to 0.74 +/- 0.26 one year after PDT. CRT and SRF significantly decreased (p < 0 001) at 3, 6, and 12 months after treatment. ONL thickness and EZ did not significantly change at any point during follow-up. Conclusions. Not significant changes were found in the ONL or EZ 12 months after PDT.
引用
收藏
页数:4
相关论文
共 23 条
  • [1] Bressler NM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1307
  • [2] Brown S B, 2001, Expert Opin Pharmacother, V2, P351
  • [3] Corticosteroids and central serous chorioretinopathy
    Carvalho-Recchia, CA
    Yannuzzi, LA
    Negrao, S
    Spaide, RF
    Freund, KB
    Rodriguez-Coleman, H
    Lenharo, M
    Iida, T
    [J]. OPHTHALMOLOGY, 2002, 109 (10) : 1834 - 1837
  • [4] Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy
    Chan, Wai-Man
    Lai, Timothy Y. Y.
    Lai, Ricky Y. K.
    Tang, Emily W. H.
    Liu, David T. L.
    Lam, Dennis S. C.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (01): : 85 - 93
  • [5] One-Year Outcomes with Half-Dose Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
    Fujita, Kyoko
    Imamura, Yutaka
    Shinoda, Kei
    Matsumoto, Celso Soiti
    Mizutani, Yoshihiro
    Hashizume, Kouhei
    Mizota, Atsushi
    Yuzawa, Mitsuko
    [J]. OPHTHALMOLOGY, 2015, 122 (03) : 555 - 561
  • [6] FLUORESCEIN ANGIOGRAPHY-GUIDED PHOTODYNAMIC THERAPY WITH HALF-DOSE VERTEPORFIN FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
    Koytak, Arif
    Erol, Kazim
    Coskun, Erol
    Asik, Nihal
    Ozturk, Hakan
    Ozerturk, Yusuf
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (10): : 1698 - 1703
  • [7] Central serous chorioretinopathy: a review of epidemiology and pathophysiology
    Liew, Gerald
    Quin, Godfrey
    Gillies, Mark
    Fraser-Bell, Samantha
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 (02) : 201 - 214
  • [8] Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy
    Loo, RH
    Scott, IU
    Flynn, HW
    Gass, JDM
    Murray, TG
    Lewis, ML
    Rosenfeld, PJ
    Smiddy, WE
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2002, 22 (01): : 19 - 24
  • [9] Matsumoto H., 2008, AM J OPHTHALMOL, V145
  • [10] The natural history of pigment epithelial detachment associated with central serous chorioretinopathy
    Mudvari, Sachin S.
    Goff, Mitchell J.
    Fu, Arthur D.
    Mcdonald, H. Richard
    Johnson, Robert N.
    Ai, Everett
    Jumper, Michael
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (09): : 1168 - 1173